Yersinia pestis is the causative agent of plague, which diverged from Yersinia pseudotuberculosis within the past 20,000 years. Although these two species share a high degree of homology at the DNA level (>90%), they differ radically in their pathogenicity and transmission. In this review, we briefly outline the known virulence factors that differentiate these two species and emphasize genetic studies that have been conducted comparing Y. pestis and Y. pseudotuberculosis.These comparisons have led to a better understanding of the genetic contributions to the differences in the virulence and pathogenicity between these two organisms and have generated information that can be applied in future diagnostic and vaccine development. Comparison of the genetic differences between Y. pestis and Y. pseudotuberculosis has also lent insight into the emergence of acute pathogens from organisms causing milder diseases.
by multiple organ failure that is thought to be a consequence of lipopolysaccharide (LPS) toxicity. 16 The third form of this disease, primary pneumonic plague, occurs by seeding of the lungs with the organism following spread from bubonic or septicemic disease. Secondary pneumonic plague occurs by spread of respiratory droplets through close contact with infected humans or animals. Secondary pneumonic infection results in a fulminate pneumonia followed by spread to the deeper organs. Without antibiotic treatment, death can occur within 24 hours. In contrast, Y. pseudotuberculosis does not generally cause illness in healthy humans, but can cause a mesenteric lymphadenitis in immunocompromised individuals following ingestion of contaminated food, while Y. enterocolitica causes gastroenteritis in healthy humans but not lethal disease. 3, 17 The difference between Y. pestis and Y. pseudotuberculosis is particularly striking considering that the genomic similarity of these species is very high and that their 16S rRNA sequences are identical. 18 Attributes contributing to the difference in disease potential between these two species were summarized previously by Brubaker. 19 Table 1 summarizes shared and unique properties of Y. pestis and Y. pseudotuberculosis that relate to virulence and physiologic differentiation. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] 64 
ROLE OF PLASMIDS IN Y. pestis VIRULENCE
The vast majority of virulence factors described in Yersiniae, including Y. pestis, are plasmid borne. Most documented Y. pestis virulence factors are encoded by a 70 kb plasmid that is common to all three Yersinia pathogen species and is, therefore, not species specific. 20, [38] [39] [40] The 70 kb plasmid is called low calcium response plasmid (pLCR/pYV), since it confers the requirement for calcium in order to grow at 37ºC. 33 The specific nomenclature of pLCR varies in different Yersinia species. pLCR was designated pCD1 (denoting calcium dependence) in Y. pestis, pYVe (denoting Yersinia virulence) in Y. enterocolitica, and pYV or pIB1 in Y. pseudotuberculosis. 41 In all animal models examined, pLCR has been shown to be absolutely critical for virulence. 33 Loss of this molecule results in complete avirulence of any of the pathogenic Yersinia, including Y. pestis. 33 The major virulence factors encoded by pLCR are the type III secretion system and the associated effector proteins, generally designated as Yersinia outer proteins (Yops). 17 Established pLCR-encoded effector proteins and virulence properties have been reviewed in greater detail elsewhere, 41 but will be summarized briefly here. YopE is a GTPase-activating protein and YopH is a protein tyrosine phosphatase, both of which are antiphagocytic. YopO/YpkA is a serine threonine kinase, YopM can transit to the host cell nucleus and has no known function, YopJ/P inhibits the proinflammatory cytokine, tumor necrosis factor-α, production and induces macrophage apoptosis. YopT is a cytotoxin that causes actin filament disruption. All the effector Yops listed here that have defined functions have been shown to disrupt intracellular signaling or result in cytoskeletal changes that interfere with phagocytosis.
The low calcium response (LCR) core region also encodes six genes that are involved in the control and translocation of the effector Yops to the target cell: yopN, yopB, yopD, tyeA, lcrG and lcrV. 41 Recently, an in vivo experiment demonstrated that Y. pestis targets specific immune cells, dendritic cells, macrophages and neutrophils for intracellular delivery of Yop proteins, but does not target B and T lymphocytes. 42 Figure 1 demonstrates GFP-labeled Y. pestis bacteria interacting with mouse macrophage cells. It has also been suggested the Yops are used to disable these specific cell populations in order to annihilate the host immune response during plague infection. The DNA sequence of the chief LCR genes (known as the LCR gene core) is 98% identical between the Y. pestis plasmid, pCD1, and two sequenced Y. enterocolitica plasmids, pYVe8081 and pYVe227. [42] [43] [44] [45] In contrast, the overall genomic homology between Y. pestis and Y. enterocolitica is approximately 23%. 46 Most identified virulence-associated genes encoded on pLCR are >92% identical in both DNA and deduced amino acid sequences between all the pLCR molecules sequenced to date across the Yersiniae. 41 However, the Y. pestis allele of yopM contains two extra copies of a repeat sequence (insertion sequence (IS) element) when compared with the DNA sequence on both sequenced Y. enterocolitica plasmids. This may be evidence of the importance of these elements in the emergence of pathogens from less virulent organisms. The impact that these DNA sequence differences have on the pathogenesis of Y. pestis versus Y. enterocolitica is yet to be determined.
The unique ability of Y. pestis to promote acute disease may be caused in part by accessory virulence factors mediated by two species-specific plasmids, pMT1/pFra and pPCP1/pPst, which are not shared by the enteropathogenic Yersiniae. There are two well-known virulence factors encoded by the approximately 100 kb plasmid, pMT1/pFra: murine toxin and fraction 1 (F1) capsular antigen. 22, 47, 48 The murine toxin is required for Y. pestis survival in the flea, and the F1 capsule is a highly immunogenic protein often assumed to be essential for full virulence of Y. pestis. 48 It is also thought that pFra may carry more potential virulence factors. 49 Du et al 50 reported F1 antigen has anti-phagocytic activity; however, strains of Y. pestis lacking F1 antigen expression (either containing pFra or not) have been reported to be virulent. [51] [52] [53] [54] Although F1-negative strains examined differ biochemically and genetically, their demonstrated virulence suggests that F1 antigen and the entire pFra plasmid probably are not required for full virulence in tested laboratory animal hosts. 17 Another plasmid specific to Y. pestis is pPCP1, a 9.6 kb plasmid which encodes a particulate plasminogen activator named Pla (Pst). 21, 55 In host tissues, Pla facilitates dissemination of Y. pestis. Presence of Pla is essential for full virulence via transmission by flea bite and other peripheral routes of infection in epidemic strains of Y. pestis. 56 In contrast, in the mouse model some endemic strains of Y. pestis, as represented by strain Pestoides F, do not require pPCP1 to be fully infectious by the subcutaneous route. 57 Expression of the plague plasminogen activator in Y. pseudotuberculosis and Escherichia coli did not significantly influence virulence in mice, 58 and a Pla -mutant of Y. pestis retained virulence in guinea pigs. Lack of pPst did not lead to an increase in LD50 with either subcutaneous or respiratory challenge, but when challenged by aerosol with cultures grown at 37ºC to mimic the person-to-person pneumonic plague cycle, the average LD50 values decreased two-fold for pPst-containing Y. pestis and 10-fold for pPst-negative Y. pestis variants, respectively. These data indicate that historical outbreaks of human pneumonic plague in the Caucasus region, where there are natural plague foci in common voles, may have been caused by pPst-negative Y. pestis strains. 59 Taken together, the data pertaining to Pla and virulence suggest this protein may be more important for virulence by the subcutaneous route of infection compared to the respiratory route. 
METHODS FOR IDENTIFYING NOVEL Y. pestis VIRULENCE FACTORS
The identification of a small number of Y. pestis unique genes encoded on plasmids that have been shown to be involved in virulence 41, 60 suggests that other chromosomally encoded factors may be responsible for the enhanced pathogenicity of this organism. Recently, studies to identify chromosomally encoded proteins of Y. pestis that may serve as chromosomally encoded virulence factors (CEVF) 61 have been undertaken. Methods successfully used for finding Yersinia CEVFs are summarized elsewhere 61 and include functional complementation screening, targeted disruption studies and large-scale mutant screening. Such recombinant DNA experiments using Yersinia DNA led to the identification of three chromosomally encoded virulence genes: yst, psa and inv. Targeted disruption of presumed virulence genes in Yersinia has been undertaken based on studies in other bacteria. 61 Functional complementation screening consist of large-scale mutant screens for potential virulence determinants. In vivo expression technology (IVET) and signature-tagged transposon mutagenesis (STM) both proved useful techniques for identifying CEVFs. 62, 63 However, most characterized CEVFs were identified in enteropathogenic Yersiniae; Revell and Miller 61 listed 24 in their review. Only psa and the high pathogenicity island (HPI) were characterized as virulence factors of Y. pestis with functions of anti-phagocytosis 64 and iron acquisition. 65 Darwin 66 recently summarized the techniques of IVET and STM applied to screening virulence genes in the Yersinia spp. IVET has been used only to study the virulence of Y. enterocolitica, 62, 67, 68 while STM has been employed to identify Y. pestis virulence associated genes. 69 Below we outline some methods that have been used by different groups or could potentially be used to screen for Y. pestis virulence factors. Genomic approaches will be emphasized.
Signature-tagged Transposon Mutagenesis (STM)
STM was developed for the isolation of bacterial virulence genes and is an insertional mutagenesis system that uses transposons carrying unique DNA sequence tags. 70 Tags from a mixed population of bacterial mutants represented in inocula and then in bacteria recovered from infected hosts were compared using DNA amplification, radiolabeling and hybridization analysis. When applied to a murine model, mutants with attenuated virulence were revealed by detecting tags absent in bacteria recovered from infected mice but present in the inocula. 63, 70 This approach allows one to screen pools of mutants together to identify those specific mutants unable to survive in vivo 63 and has been used successfully for many different bacterial species, including the enteric Yersinia and Y. pestis. 69, [71] [72] [73] Sixteen putative attenuated mutants of Y. pestis were identified using STM, including mutants with interruptions in genes such as the virulence regulator, lcrF; virulence-associated genes involved in global bacterial physiology (e.g., purH, purK, dnaE and greA); and genes encoding hypothetical polypeptides. 69 Flashner et al 69 also found that one of the avirulent mutant strains was disrupted in the pcm locus which was previously shown to be involved in bacterial response to environmental stress.
Comparative Genomic Studies
Since diverse Yersinia genome sequences have now been completed, it is possible to use comparative genome analysis to select genes for further investigation of contributions to pathogenesis, particularly of genes unique to Y. pestis. Directed mutagenesis followed with animal testing is an expedient approach to the identification of undiscovered Y. pestis virulence factors. Generally, comparative genomic studies include DNA microarray hybridizations and in silico computational genomic analysis. The application of both methods to Y. pestis studies will be discussed in the following sections.
DNA microarray analysis DNA microarrays have provided a powerful tool in genomics research. They are widely used to determine genome-wide mRNA expression levels in a single experiment 74 and are also used to probe for genetic differences and changes between strains at the intra-or interspecies level. 75, 76 DNA microarray analysis represents an ideal methodology to compare closely related genomes. The technique was applied to compare the genomic contents of different strains, serotypes and biovars of Y. pestis, and its ancestor Y. pseudotuberculosis, before the DNA sequence of the latter was released. [10] [11] [12] Hinchliffe et al 10 reported that 11 regions in the genome for the strain CO92 were absent or highly divergent in all 10 Y. pseudotuberculosis strains tested by DNA microarray hybridization. In the same year, Zhou et al 11, 12 also reported similar regions that were specific to Y. pestis (table 2). These findings provide critical information, which can be used for directed mutagenesis of Y. pestis-specific genes, and thus, are useful for identifying Y. pestis-specific virulence factors or vaccine candidates. Indeed, a recent protein microarray study showed that the Y. pestis-specific genes YPO0388, YO2090 and YPO2093 encoded proteins that induced significant antibody response in the immunized rabbit. 77 These results yield clues about the role of these genes in pathogenicity and immunity, and beg for further investigation into these possibilities and for the potential use of these immunogens as vaccine candidates.
The DNA microarray is also an ideal tool for genome-wide analysis of gene regulation at the transcriptional level, as mentioned above. Y. pestis, the etiologic agent of plague, must acclimatize itself during its life cycle to shifts between the temperature of the flea (26ºC) and that of the warm-blooded host (37ºC). It is known that in the adaptation to these temperature shifts, significant phenotype variations occur such as in virulence, nutrient requirements, enzyme activity, capsule formation, and pigmentation production. 14 Differential gene expression at these two temperatures is thought to allow the bacterium to colonize its host efficiently, leading to its pathogenesis. Temperature-induced changes occurred in the transcription of genes encoding proven or predicted virulence factors, regulators, metabolism-associated proteins, prophages and hypothetical proteins. 14 A few groups have used whole-genome DNA microarray analysis to investigate transcriptional regulation upon the upshift of growth temperature from 26ºC to 37ºC in a chemically defined medium with or without 2.5 mM CaCl. 13, 14 Genes which were upregulated quickly after the shift to 37ºC may be valid Y. pestis virulence factor candidates, since early changes in transcriptional expression due to temperature shift probably reflect adaptation to the host rather than changes solely integral to the onset of bacteriostasis. Transcriptional profiles reported by Motin et al 13 revealed thermal induction of 51, 4 and 13 genes or open reading frames on pCD1, pPCP and pMT, respectively. In addition to type III secretion-associated proteins (e.g., Yops) that are known to be induced upon the upshift to 37ºC, 15 novel thermoregulated genes that may contribute to Yersiniae virulence were found on the three plasmids. The majority of the thermoregulated genes on pCD1 were downregulated by Ca 2+ and matching previous reports that Yop genes and their regulators are all upregulated at 37ºC. 13, 20 In contrast, Ca 2+ concentration had little effect on chromosomal or plasmid-borne (i.e., pCP1, pMT1) genes. Motin et al 13 demonstrated that of the genes tested, 235 were thermally upregulated and 274 were thermally downregulated. Chromosomal genes involved in carbon and energy metabolism, nitrogen and amino acid metabolism, lipid metabolism, nucleotide metabolism and macromolecular synthesis were found to be strongly or modestly downregulated when the temperature was shifted to 37ºC. Additionally, a significant number of genes encoding putative exported, membrane or unknown proteins were upregulated at 37ºC. 13 Overall, the results of Motin et al 13 indicated that, in nature, plague bacilli favor fermentative patterns of metabolism during slow growth within the flea, but exhibit pronounced oxidative catabolism during rapid proliferation in the host.
Differential transcription during temperature shift also provided a useful list of putative virulence-associated genes, 13 particularly those genes that are upregulated at 37ºC. Han et al 14 78 Of these differentially regulated genes, 349 were chromosomally located, 48 on pCD1, and 4 each on pMT1 and pPCP1. The 235 Y. pestis genes that were upregulated included 27 genes involved in the biosynthesis of a number of amino acids, 33 genes associated with the Yop-ysc type III secretion system, and genes encoded in the virulence-associated pigmentation (pgm) region for yersiniabactin iron acquisition and hemin uptake. Interestingly, genes for two other virulence factors, the pH 6.0 antigen (psa operon) and the plasminogen activator Pla, were downregulated under these conditions. Genes encoding enzymes that deactivate reactive oxygen species were also downregulated, similar to what was observed by Motin et al 13 and again indicated these genes may not be involved in virulence. This study yielded both new and reinforcing information about the involvement (or lack thereof) of identified virulence factors in primary pneumonic infection, and also the potential involvement of previously unlinked systems. These genes can now be considered for more focused pathogenesis studies. A whole genome sequence of Y. pestis strain 9100l 8 provides an even wider window to more fully understand the genetic pathogenesis of Y. pestis. Strain 91001 is reported to be representative of an atypical Y. pestis biovar that causes endemic plague in local rodents, such as Brandt's voles, but is avirulent in humans and therefore diverged from strains capable of causing epidemic disease. 80 The genome of 91001 consists of one chromosome and four plasmids (pPCP1, pCD1, pMT1 and pCRY). The pPCP1 plasmid of strain 91001 is almost identical to the counterparts from reference strains (CO92 and KIM). Compared with the molecules encoded by epidemic strains CO92 and KIM, plasmids pCD1 and pMT1 have slightly different architecture. The pCRY molecule is a novel cryptic plasmid identified during this study. It is a 21,742 bp plasmid that harbors a cryptic type IV secretory system and proved to be unnecessary for pathogenicity. Many genetic variations were found in comparing the chromosomes of these three Y. pestis strains. Rearrangements mediated by insertion elements appear to have dramatically altered the structure of the strain 91001 chromosome in comparison with strains CO92 and KIM. A very interesting finding was the absence of a large genomic region in the 91001 chromosome (table 3) that may contribute to its host specificity and unique nonpathogenicity in humans. This 33 kb region specific to strains CO92 and KIM seems to encode prophage proteins with no obvious virulence motifs. Most of the other genes found to be specific to Y. pestis versus Y. pseudotuberculosis were putative phage genes or phage-related genes. 10, 11 It is thought that prophages are a major driving factor in the evolution of bacterial genomes by mediating lateral gene transfer. 81 It is well known that virulence genes are encoded on bacteriophage. [82] [83] [84] [85] 86 These results suggest a sobering example of how a highly virulent epidemic clone can suddenly emerge from a less virulent one by genetic changes in a closely related progenitor.
Genome comparisons-based computational analysis

Selection of Target Genes for Directed Mutagenesis
The availability of complete Yersinia genome sequences has provided ample opportunity for genomic comparisons to identify genes involved in enhanced human virulence by Y. pestis. A systematic mutational analysis of genes in their normal location can provide significant insight into their function. A number of general allelic replacement methods can be used to inactivate bacterial chromosome genes, but these all require a relatively complicated process, such as creating the gene disruption on a suitable plasmid before recombining it onto the chromosome. Recently a very efficient one-step recombination system was developed for chromosome engineering in E. coli. [87] [88] [89] The phage lambda red recombinase system was exploited for this purpose. 87 By using conditions favoring efficient electroporation of appropriately designed polymerase chain reaction products into lambda red backgrounds, any gene of choice can be recombined directly into the chromosome while requiring only a single marker encoded within the polymerase chain reaction product. The only information needed to do this is the sequence of the gene and its immediate flanking region. This efficient genomic engineering process has also been successfully adapted to Yersinia mutagenesis 90 and used as a tool for directed mutagenesis for Y. pestis virulence factor identification.
MODELS FOR Y. pestis PATHOGENESIS STUDIES
Mice, rats and guinea pigs have been used as animal models of plague since the discovery of the plague bacillus, primarily to confirm the identity of Y. pestis isolates from suspected plague cases. 91, 92 Rats and guinea pigs infected with Y. pestis show the enlargement of regional lymph nodes, septicemia and rapid death that resembles human bubonic plague. 93 In contrast, mice do not develop typical buboes, although their lymph nodes are infected and sometimes enlarged. However, the considerable variation in susceptibility to plague among individual rats 94 has made mice the most commonly used model for molecular pathogenesis and vaccine studies since the 1950s. 95 The monkey has also been used as an animal model for plague, 96 Although mammalian animal models are widely accepted for assessment of Y. pestis pathogenesis, an alternative approach using non-mammalian, genetically tractable host organisms is attractive. 98 Animal models for studying the pathogenesis of bacteria as mentioned above are genetically unwieldy and do not lend themselves easily to experimental analysis. 98 Also, there are cost and ethical restraints on the use of laboratory mammals. It has been demonstrated that the nematode Caenorhabditis elegans can be infected by human Yersinia pathogens as well as other bacteria. 99 Moreover, the mechanisms of invasion and host responses may parallel that in mammalian cells. Recently a C. elegans model of Yersinia infection was used to investigate pathogenicity and the evolutionary divergence of the genus. 100 In this study, three strains of Y. pestis, including a strain lacking pMT1, caused blockage and death of C. elegans. One strain lacking the haemin storage (hms) locus had no effect on the host. Similarly, 15 strains of Y. enterocolitica caused no deleterious effect on the host. In contrast, Y. pseudotuberculosis exhibited different levels of pathogenicity in this model.
CONCLUSION
Plague research now stands at the precipice of a new era with the biological implications of recently generated genomic sequences still largely unexplored. The genomic approaches outlined here will significantly benefit the search for novel Y. pestis virulence determinants and will further our understanding of global regulatory systems that are integral to this pathogen's life cycle, and its survival in disparate hosts. Comparative genetic studies of Y. pestis and Y. pseudotuberculosis, including DNA microarray analysis and computational sequence analysis, can provide basic information on the genetic differences between these two highly related species. These genetic differences will then be targeted for more intensive study to determine their contribution to the contrast in disease potential between these species. Undiscovered genes involved in virulence are likely to be identified as newly developed technologies are employed, including molecular tools such as more efficient and powerful mutagenesis systems and also more suitable infection models, including refined mammalian and novel nonmammalian systems. Discoveries of new Y. pestis virulence factors can, in turn, be exploited for medical applications including diagnostic, vaccine and drug development. Application of these techniques to study the life cycle of Y. pestis in the arthropod host may yield a more detailed understanding of molecular events within that host and may reveal potential applications to control endemic foci. Finally, a deeper understanding of the plague disease process will provide new information about bacterial pathogenesis, including a detailed molecular model of the rapid emergence of a lethal pathogen from a moderate pathogen, a potential to understand the molecular basis of host range and epidemic eruptions, as well as the possible elucidation of shared mechanisms of bacterial pathogenesis that are yet to be described.
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